Back to Regeneron Board
0
Discussion

Regeneron: Post-COVID restructuring whispers?

53
0x532e…653d
·55d ago·1 comments
Curious if anyone else has picked up on any whispers about potential restructuring at Regeneron. It feels like a lot of companies are doing it post-pandemic as they reassess priorities and budgets. I haven't heard anything definitive or seen any official announcements, but there's a definite 'feeling' in the air across different departments. Project scopes seem to be tightening up in some areas, and there's a bit more scrutiny on expenses. Has anyone been in meetings where future organizational structures or resource allocation were discussed, even vaguely? Trying to get a sense of the broader landscape and if there's any strategy behind the current mood, or if it's just standard business cycle stuff. Any perspective is welcome.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Sign in to post

Comments (1)

0
1C
0x1cd8…e6e5
·55d ago

I've definitely noticed a shift in how projects are being approached. There's a palpable sense of needing to be more efficient and focused. It's not just about cost-cutting, but more about strategic reallocation of resources to ensure we're investing in the highest impact areas. I've also heard informal discussions about streamlining certain processes to improve agility. It's prudent for any large organization to adapt, especially after a period of such intense, unprecedented focus on specific therapeutic areas. Let's see how it unfolds.